These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 26038706)

  • 1. Incorporation of concentration data below the limit of quantification in population pharmacokinetic analyses.
    Keizer RJ; Jansen RS; Rosing H; Thijssen B; Beijnen JH; Schellens JH; Huitema AD
    Pharmacol Res Perspect; 2015 Mar; 3(2):e00131. PubMed ID: 26038706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Bayesian approach for PK/PD modeling with PD data below limit of quantification.
    Zhou H; Hartford A; Tsai K
    J Biopharm Stat; 2012; 22(6):1220-43. PubMed ID: 23075019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of censoring data below an arbitrary quantification limit on structural model misspecification.
    Byon W; Fletcher CV; Brundage RC
    J Pharmacokinet Pharmacodyn; 2008 Feb; 35(1):101-16. PubMed ID: 17963024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [To consider negative viral loads below the limit of quantification can lead to errors in the diagnosis and treatment of hepatitis C virus infection].
    Acero Fernández D; Ferri Iglesias MJ; López Nuñez C; Louvrie Freire R; Aldeguer Manté X
    Gastroenterol Hepatol; 2013; 36(7):443-9. PubMed ID: 23849764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating area under the curve and relative exposure in a pharmacokinetic study with data below quantification limit.
    Fang L; Chen P; Ke C; Lee E
    J Biopharm Stat; 2011 Jan; 21(1):66-76. PubMed ID: 21191855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of low percentage of data below the quantification limit on parameter estimates of pharmacokinetic models.
    Xu XS; Dunne A; Kimko H; Nandy P; Vermeulen A
    J Pharmacokinet Pharmacodyn; 2011 Aug; 38(4):423-32. PubMed ID: 21626437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Data Analysis Protocol for the Development and Evaluation of Population Pharmacokinetic Models for Incorporation Into the Web-Accessible Population Pharmacokinetic Service - Hemophilia (WAPPS-Hemo).
    McEneny-King A; Foster G; Iorio A; Edginton AN
    JMIR Res Protoc; 2016 Dec; 5(4):e232. PubMed ID: 27927609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical relevance of detectable but not quantifiable hepatitis C virus RNA during boceprevir or telaprevir treatment.
    Harrington PR; Zeng W; Naeger LK
    Hepatology; 2012 Apr; 55(4):1048-57. PubMed ID: 22095516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of Parameter Estimations in Tumor Growth Inhibition Models on Xenografted Animals: a Novel Method to Handle the Interval Censoring Caused by Measurement of Smaller Tumors.
    Pierrillas PB; Tod M; Amiel M; Chenel M; Henin E
    AAPS J; 2016 Mar; 18(2):404-15. PubMed ID: 26757730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluations of Bayesian and maximum likelihood methods in PK models with below-quantification-limit data.
    Yang S; Roger J
    Pharm Stat; 2010; 9(4):313-30. PubMed ID: 20043295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Approaches to handling pharmacodynamic baseline responses.
    Dansirikul C; Silber HE; Karlsson MO
    J Pharmacokinet Pharmacodyn; 2008 Jun; 35(3):269-83. PubMed ID: 18446428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous versus sequential pharmacokinetic-pharmacodynamic population analysis using an iterative two-stage Bayesian technique.
    Proost JH; Schiere S; Eleveld DJ; Wierda JM
    Biopharm Drug Dispos; 2007 Nov; 28(8):455-73. PubMed ID: 17847121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Likelihood based approaches to handling data below the quantification limit using NONMEM VI.
    Ahn JE; Karlsson MO; Dunne A; Ludden TM
    J Pharmacokinet Pharmacodyn; 2008 Aug; 35(4):401-21. PubMed ID: 18686017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Observations below multiple lower limits of quantification: How to estimate the mean and variance.
    Berger T; Hilgers RD; Heussen N
    Biom J; 2019 Sep; 61(5):1258-1269. PubMed ID: 30221408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An innovative phase I population pharmacokinetic approach to investigate the pharmacokinetics of an intranasal fentanyl spray in healthy subjects.
    Plock N; Facius A; Hartmann L; Baumann S; Nave R
    Int J Clin Pharmacol Ther; 2013 Jun; 51(6):495-508. PubMed ID: 23611571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetics and bayesian estimator of cyclosporine in pediatric renal transplant patients.
    Irtan S; Saint-Marcoux F; Rousseau A; Zhang D; Leroy V; Marquet P; Jacqz-Aigrain E
    Ther Drug Monit; 2007 Feb; 29(1):96-102. PubMed ID: 17304156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. External Evaluation of Population Pharmacokinetic Models of Methotrexate for Model-Informed Precision Dosing in Pediatric Patients with Acute Lymphoid Leukemia.
    Wang S; Yin Q; Yang M; Cheng Z; Xie F
    Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36839891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ways to fit a PK model with some data below the quantification limit.
    Beal SL
    J Pharmacokinet Pharmacodyn; 2001 Oct; 28(5):481-504. PubMed ID: 11768292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a population pharmacokinetic model for carbamazepine based on sparse therapeutic monitoring data from pediatric patients with epilepsy.
    Carlsson KC; Hoem NO; Glauser T; Vinks AA
    Clin Ther; 2005 May; 27(5):618-26. PubMed ID: 15978311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Comparison of the β-Substitution Method and a Bayesian Method for Analyzing Left-Censored Data.
    Huynh T; Quick H; Ramachandran G; Banerjee S; Stenzel M; Sandler DP; Engel LS; Kwok RK; Blair A; Stewart PA
    Ann Occup Hyg; 2016 Jan; 60(1):56-73. PubMed ID: 26209598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.